Effect of Cholecystokinin on Gastric Motility in Humansa
- 1 March 1994
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 713 (1) , 219-225
- https://doi.org/10.1111/j.1749-6632.1994.tb44068.x
Abstract
Gastric emptying after food ingestion is regulated by neural and hormonal factors. However, the relative contributions of each pathway is not yet clearly defined. The classic gut hormone CCK seems to be involved in the regulation of gastric emptying in humans. Experimental evidence is best for gastric emptying of liquid meals that release CCK from the duodenum: (1) CCK infused at postprandial plasma concentrations inhibits gastric emptying of a liquid and a semisolid meal. (2) Administration of the CCK antagonist loxiglumide significantly accelerated gastric emptying of a liquid mixed meal and a glucose meal. Discrepant results with the antagonist MK329 are difficult to explain considering the marked acceleration of gastric emptying rates by the specific and potent antagonist MK329 shown in several animal studies. Taken together, current information favors the conclusion, however, that CCK mainly controls gastric emptying of the liquid but not the solid components. Thus, CCK is involved in the physiologic regulation of gastric emptying and gastric motility in man. Blocking CCK-A receptors accelerates gastric emptying of liquid meals and abolishes the gastrocolonic reflex. Therefore, CCK may play a role as a common regulator of postprandial gallbladder contraction and pancreatic enzyme secretion as well as of gastric emptying rates under certain conditions. Such common control would optimize the nutrient-to-digestive juices concentration ratio. The importance of endogenous CCK on gastric emptying of solid meals, however, is poorly understood and remains to be defined. Only very limited information is available on gastric motility. Much more work has to be done before a clear concept can be developed.Keywords
This publication has 25 references indexed in Scilit:
- The Rational Use of CCK Antagonists in Irritable Bowel SyndromePublished by Springer Nature ,1991
- The Morphological Localization of Cholecystokinin and Its Binding Sites in the Diffuse Neuroendocrine SystemPublished by Springer Nature ,1991
- Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.Journal of Clinical Investigation, 1990
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.Journal of Clinical Investigation, 1989
- ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONSThe Lancet, 1989
- Dysmotility of the small intestine in irritable bowel syndrome.Gut, 1988
- Regulation of gastric emptying in humans by cholecystokinin.Journal of Clinical Investigation, 1986
- Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.Journal of Clinical Investigation, 1985
- EFFECT OF CHOLECYSTOKININ ON COLONIC MOTILITY AND SYMPTOMS IN PATIENTS WITH THE IRRITABLE-BOWEL SYNDROMEThe Lancet, 1973
- Cholecystokinin and Pancreozymin, one single Hormone?Acta Physiologica Scandinavica, 1966